Skip to main content

GlaxoSmithKline acquires Novartis stake in Consumer Healthcare venture for $13B

GlaxoSmithKline announces that it has reached an agreement with Novartis for the buyout of Novartis' 36.5% stake in their Consumer Healthcare joint venture for $13B.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.